InvestorsHub Logo
Followers 2
Posts 696
Boards Moderated 0
Alias Born 01/13/2001

Re: None

Saturday, 11/26/2005 9:53:47 AM

Saturday, November 26, 2005 9:53:47 AM

Post# of 82595
I just receveived this email from a friend, which may add relevance to the ongoing debate over Ovanome studies at Moffitt.

Genelex and Roche are mentioned....
But the most important sentence in the 4 page article..


" New predictive genetic tests for segment population.......
"Because the tests are usually categorized as clinical services,
they dont require FDA approval-which leave the doors wide open
for all kinds of products."
Maybe Tony is approaching this from another angle..


The above were in reference to an article in Oprah '05. I would presume it is the latest issue. My thoughts on this is that the FDA doesn't have authority over the implimentation of prescribing, but only on that which is perscribed. These "authoritative tests" only address the probably reaction one would have in taking a particular regimine that was previously approved. I think the gist of the whole debate is how to market these tests so they are used by the prescribing physician. The moral debate can be overcome w/ facts, as in the Bidil case.

Peace, Blessings & Boat Drinks, Easy